Singer DE - Search Results

1

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.

Mahaffey KW, Stevens SR, White HD, Nessel CC, Goodman SG, Piccini JP, Patel MR, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Califf RM, Fox KA, Breithardt G; ROCKET AF Investigators. Mahaffey KW, et al. Among authors: singer de. Eur Heart J. 2014 Jan;35(4):233-41. doi: 10.1093/eurheartj/eht428. Epub 2013 Oct 15. Eur Heart J. 2014. PMID: 24132190 Free PMC article. Clinical Trial.

2

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. van Walraven C, et al. Among authors: singer de. JAMA. 2002 Nov 20;288(19):2441-8. doi: 10.1001/jama.288.19.2441. JAMA. 2002. PMID: 12435257

3

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE. Go AS, et al. Among authors: singer de. JAMA. 2003 Nov 26;290(20):2685-92. doi: 10.1001/jama.290.20.2685. JAMA. 2003. PMID: 14645310

4

Anticoagulation for atrial fibrillation.

Fang MC, Singer DE. Fang MC, et al. Among authors: singer de. Cardiol Clin. 2004 Feb;22(1):47-62. doi: 10.1016/s0733-8651(03)00115-2. Cardiol Clin. 2004. PMID: 14994847 Review.

5

Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in.

van Walraven C, Hart RG, Singer DE, Koudstaal PJ, Connolly S. van Walraven C, et al. Among authors: singer de. Card Electrophysiol Rev. 2003 Dec;7(4):374-8. doi: 10.1023/B:CEPR.0000023143.98705.ee. Card Electrophysiol Rev. 2003. PMID: 15071258 Review.

6

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Singer DE, et al. Chest. 2004 Sep;126(3 Suppl):429S-456S. doi: 10.1378/chest.126.3_suppl.429S. Chest. 2004. PMID: 15383480 Review.

7

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Fang MC, et al. Among authors: singer de. Circulation. 2005 Sep 20;112(12):1687-91. doi: 10.1161/CIRCULATIONAHA.105.553438. Epub 2005 Sep 12. Circulation. 2005. PMID: 16157766 Free PMC article.

8

Antithrombotic therapy for stroke prevention in atrial fibrillation.

Go AS, Fang MC, Singer DE. Go AS, et al. Among authors: singer de. Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):108-24. doi: 10.1016/j.pcad.2005.06.007. Prog Cardiovasc Dis. 2005. PMID: 16253651 Review.

9

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GYH, Manning WJ. Singer DE, et al. Chest. 2008 Jun;133(6 Suppl):546S-592S. doi: 10.1378/chest.08-0678. Chest. 2008. PMID: 18574273

10

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.

van Walraven C, Hart RG, Connolly S, Austin PC, Mant J, Hobbs FD, Koudstaal PJ, Petersen P, Perez-Gomez F, Knottnerus JA, Boode B, Ezekowitz MD, Singer DE. van Walraven C, et al. Among authors: singer de. Stroke. 2009 Apr;40(4):1410-6. doi: 10.1161/STROKEAHA.108.526988. Epub 2009 Jan 29. Stroke. 2009. PMID: 19182090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page